Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,818,807
  • Shares Outstanding, K 228,234
  • Annual Sales, $ 1,502 M
  • Annual Income, $ 190,380 K
  • 36-Month Beta 0.89
  • Price/Sales 5.80
  • Price/Cash Flow 15.74
  • Price/Book 3.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.26
  • Number of Estimates 6
  • High Estimate 0.29
  • Low Estimate 0.25
  • Prior Year 0.26
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.72 +8.17%
on 02/05/19
38.72 -0.21%
on 02/15/19
+2.37 (+6.53%)
since 01/15/19
3-Month
32.33 +19.52%
on 12/24/18
38.72 -0.21%
on 02/15/19
+4.13 (+11.97%)
since 11/15/18
52-Week
31.10 +24.24%
on 04/06/18
39.45 -2.05%
on 08/29/18
+4.84 (+14.32%)
since 02/15/18

Most Recent Stories

More News
Pacific Biosciences (PACB) Incurs Q4 Loss, Revenues Fall Y/Y

Pacific Biosciences' (PACB) dismal fourth-quarter 2018 results can be attributed to disappointing performance by the company's Product Revenue segment.

PACB : 7.13 (+0.71%)
ILMN : 299.82 (+2.51%)
TMO : 252.49 (+2.58%)
QGEN : 38.64 (+1.18%)
Qiagen Nv Set to Possibly Rebound After Yesterday's Selloff of 1.36%

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $36.02 to a high of $36.97. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $36.50 on...

QGEN : 38.64 (+1.18%)
QIAGEN's (QGEN) Q4 Earnings In Line, Revenues Miss Mark

QIAGEN's (QGEN) suffers sluggish sales at Americas. However, the company delivers strong global growth.

SRDX : 56.81 (+5.73%)
VAR : 132.74 (+0.74%)
QGEN : 38.64 (+1.18%)
ANGO : 23.46 (+1.34%)
Cancer Drug Development Shows That Government and Private Sector can Work Together

Considering that yesterday, February 4, was World Cancer Day, it is encouraging that the private sector and the U.S. government are mutually trying to solve a serious problem and are in fact, working closely...

EOLS : 27.38 (+0.44%)
AGEN : 3.61 (+1.98%)
TTNP : 1.53 (-1.92%)
QGEN : 38.64 (+1.18%)
MBRX : 1.47 (unch)
Qiagen (QGEN) Q4 Earnings Meet Estimates

Qiagen (QGEN) delivered earnings and revenue surprises of 0.00% and -1.43%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

QGEN : 38.64 (+1.18%)
Qiagen: 4Q Earnings Snapshot

VENLO, Netherlands (AP) _ Qiagen NV (QGEN) on Monday reported fourth-quarter net income of $61 million, after reporting a loss in the same period a year earlier.

QGEN : 38.64 (+1.18%)
QIAGEN Informatics Solutions Chosen to Support Genomics England's Bold Five Million Genomes in Five Years Project

QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced that Genomics England have selected QIAGEN's QCI (QIAGEN Clinical Insights)portfolio offering on behalf of the NHS in...

QGEN : 38.64 (+1.18%)
Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for

Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

QGEN : 38.64 (+1.18%)
Watch for Qiagen Nv to Potentially Pullback After Gaining 1.12% Yesterday

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $37.03 to a high of $37.25. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $37.01...

QGEN : 38.64 (+1.18%)
Look for Shares of Qiagen Nv to Potentially Pullback after Yesterday's 1.12% Rise

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $37.03 to a high of $37.25. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $37.01...

QGEN : 38.64 (+1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade QGEN with:

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 38.98
1st Resistance Point 38.81
Last Price 38.64
1st Support Level 38.38
2nd Support Level 38.12

See More

52-Week High 39.45
Last Price 38.64
Fibonacci 61.8% 36.26
Fibonacci 50% 35.28
Fibonacci 38.2% 34.29
52-Week Low 31.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar